The third analysis of the bicalutamide Early Prostate Cancer programme
- PMID: 16469002
- DOI: 10.1111/j.1464-410X.2006.06118.x
The third analysis of the bicalutamide Early Prostate Cancer programme
Comment on
-
Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer.BJU Int. 2006 Feb;97(2):247-54. doi: 10.1111/j.1464-410X.2005.06051.x. BJU Int. 2006. PMID: 16430622 Clinical Trial.
-
Apples and oranges. Re: 7.4-year update of the ongoing bicalutamide Early Prostate Cancer (EPC) trial programme.BJU Int. 2006 Mar;97(3):435-8. doi: 10.1111/j.1464-410X.2006.06088.x. BJU Int. 2006. PMID: 16469001 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
